Using Early Access Programs (EAPs) to give patients with life threatening conditions access to medic...
Read moreOur Market Access experts investigate what early access opportunities are available in China to enab...
Read moreMHRA announces UK will introduce new framework aimed at making the manufacture of innovative medicin...
Read moreIntroduction Following Brexit, regulatory oversight in the UK has switched from the European Medicin...
Read moreThe changes cover how topics are chosen, the steps and stages in each evaluation and how evidence is...
Read moreThe aim of MAPPs is to enable quicker access for patients whilst providing adequate and evolving evi...
Read moreIncluded is the P&R challenges faced by the PCSK9 inhibitors as well as how payers are trying to ove...
Read more